SAR441000
TED15297
Phase 1 small_molecule terminated
Quick answer
SAR441000 for Metastatic Neoplasm is a Phase 1 program (small_molecule) at Atrium Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atrium Therapeutics
- Indication
- Metastatic Neoplasm
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated